Primary sequences have been reported for two alanine-accepting tRNAs from Escherichia coli. These are tRNAlAa from E. coli B (15) and tRNAIAla from E. coli K-12 (6) . Each contains uridine-5-oxyacetic acid (V) in the anticodon 5'-VGC-3', which may be expected to pair with the codons GCA, GCG, and GCU. Alanine tRNAs that read GCC have been observed in other organisms, but a tRNA with this (C) coding specificity has not previously been isolated from E. coli. The tRNA species reported here has the anticodon 5'-GGC-3', which is complementary to the alanine codons GCC and GCU.
Alanine-accepting tRNAs were obtained from various derivatives of the E. coli K-12 strain W3110. The growth of bacterial cells and extraction of RNA have been described (b) 
Cloverleaf model of the sequence of tRNAGac. At position 8 (asterisk), we observed both U and a second nucleoside, presumed to be a modified U. G46 is predominantly unmodified (dagger); a small amount of m'G was, however, found at this position.
previously (9) . Bulk tRNA was aminoacylated with [14C] alanine, applied to an RPC-5 column, and eluted with a linear 0.55 to 0.82 M NaCl gradient, essentially as described previously (10) . Fractions containing [14C]alanyl-tRNA (0.60 to 0.63 M NaCI) were pooled. The tRNA thus obtained was separated by polyacrylamide gel electrophoresis as previously described, with minor modifications (10) . The procedure for RNA sequence analysis was the rapid print-readout method of Gupta and Randerath (4).
The nucleotide sequence of tRNAAlc, as determined in the ammonium sulfate chromatographic system described by Gupta and Randerath (4), is shown in Fig. 1 . It can be read directly, 5' to 3' (left to right), from the 5' end of the molecule to the penultimate nucleotide. The 3' terminal A is not evident because hydrolysis at this position results in a nucleoside, which is not a substrate for polynucleotide kinase (11) . The sequence was substantiated in the formate chromatographic system (4) (data not shown).
The tRNAAlc is shown in cloverleaf structure in Fig. 2 .
The sequence of tRNAGGC exhibits extensive homology with that determined for tRNA~Ala (6) and its gene (16) . This is the first E. coli tRNA, however, found to have an anticodon complementary to GCC. It is unique among sequenced alanine tRNAs because it contains G in the 5' position of the anticodon. Alanine tRNAs capable of reading GCC have been found in bakers' and brewers' yeast (8) , Torulopsis utilis (14) , and Bombyx mori (12) . All contain inosine (I) in the anticodon (5'-IGC-3') and therefore may be expected to recognize GCA and GCU in addition to GCC.
The "semi-invariant" position 32 of the E. coli tRNAGGc contains A instead of the expected pyrimidine nucleoside. This is unusual but not without precedent, as A32 was also found in a leucine tRNA from Bacillus subtilis (2) and in a threonine tRNA from spinach chloroplast (5). Initiator methionine tRNA from Saccharomyces cerevisiae yeast mitochondria contains G32 (1). The "invariant" position 8 contains U or s4U in almost all tRNAs of known sequence (13) . Sequence analysis of tRNAAac shows the expected U at this position and another, unknown nucleoside. The latter is assumed to be modified U, but it does not behave chromatographically like s4U.
Using the method of Gupta and Randerath (data not shown), we have determined that the same nucleosides occupy position 8 in the sequence of tRNAAla. The sequence of tRNA Ala reported by Lund and Dahlberg (6) , however, has s4U at position 8. It could be that the unidentified nucleoside that we observed contained a further modification of S4U.
The amino acid acceptor stem of tRNAGGc includes a G3-U70 pair. Although unconventional base pairings are not uncommon in the acceptor stems of tRNAs (3), the G3-U70 pair is of interest because it is almost invariant among alanine tRNAs that are not from mammalian mitochondria. Grosjean et al. (3) suggest that this nonstandard pairing could have some functional significance. Indeed, a role for the G3-U70 pairing in aminoacylation specificity has been suggested on the basis of analyses of lysine tRNA mutants that may be misacylated with alanine (7, 10) .
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